心力衰竭和铁缺乏症患者的静脉铁疗法:随机对照试验的更新元分析
Mohamed Hamed1, Sheref A Elseidy2, Asmaa Ahmed2
1Department of Internal Medicine, Florida Atlantic University, Boca Raton, FL, USA.
Heliyon
|June 29, 2023
概括
静脉注射铁可以减少铁缺乏症患者的心力衰竭住院的情况. 这项对12个RCT的元分析发现,静脉注射铁降低了复合结果和住院治疗,改善了心力衰竭症状.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 临床研究 临床研究
背景情况:
- 心力衰竭 (HF) 和缺铁 (ID) 经常同时存在.
- 静脉注射 (IV) 铁是HF患者ID的潜在治疗方法.
- 之前对IV铁的随机临床试验 (RCT) 对于HF和ID显示了不一致的结果.
研究的目的:
- 为了评估IV铁的有效性和安全性,在患有HF和ID的患者.
- 综合来自RCT的证据,以确定IV铁对HF住院和死亡率的影响.
主要方法:
- 在MEDLINE,EMBASE和OVID数据库中进行了系统的电子搜索,直到2022年11月.
- 包括RCT专注于ID的HF患者的IV铁.
- 主要结局是HF住院或心血管死亡率的组合,以及单独的HF住院. 随机效应模型被用于分析.
主要成果:
- 分析了12个涉及3,492名患者的RCT.
- 静脉注射铁显著降低了HF住院或心血管死亡率 (RR 0.72;95% CI 0.59-0.88) 和HF住院 (RR 0.69;95% CI 0.57-0.85) 的复合.
- 在心血管或全因死亡率方面没有发现显著差异. 静脉注射铁改善了纽约心脏协会的排名和左心室喷射率 (LVEF).
结论:
- 静脉注射铁与HF住院和HF和ID患者综合结局的减少有关.
- 这些好处主要来自于HF住院病例的减少.
- 进一步的研究可能会证实对死亡率和生活质量的长期影响.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...


